Zacks Investment Research on MSN
Incyte's rare blood cancer therapy gets FDA's breakthrough status
Incyte INCY announced that the FDA has granted the Breakthrough Therapy designation to its investigational, first-in-class, ...
PRINCETON, N.J.(AP) — PRINCETON, N.J. (AP) — Amicus Therapeutics Inc. (FOLD) on Tuesday reported third-quarter profit of $17.3 million. The Princeton, New Jersey-based company said it had profit of 6 ...
CARY, N.C. (AP) — CARY, N.C. (AP) — Heron Therapeutics Inc. (HRTX) on Tuesday reported a loss of $17.5 million in its third quarter. The Cary, North Carolina-based company said it had a loss of 10 ...
SAN DIEGO (AP) — SAN DIEGO (AP) — Halozyme Therapeutics Inc. (HALO) on Monday reported third-quarter earnings of $175.2 million. On a per-share basis, the San Diego-based company said it had net ...
CAMBRIDGE, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, ...
SAN DIEGO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) ...
Hosted on MSN
Needham Upgrades Amicus Therapeutics (FOLD)
Fintel reports that on September 18, 2025, Needham upgraded their outlook for Amicus Therapeutics (NasdaqGM:FOLD) from Hold to Buy. Analyst Price Forecast Suggests 103.49% Upside As of September 13, ...
The chief executive officer of Gyre Therapeutics has stepped down. The biotechnology company said Monday that Han Ying has resigned as CEO and will transition to the role of senior vice president of ...
U.S. stock futures were lower this morning, with the Dow futures falling around 300 points on Friday. Shares of Frequency Electronics, Inc. (NASDAQ:FEIM) fell sharply in today's pre-market trading ...
The MarketWatch News Department was not involved in the creation of this content. Veteran medtech executive brings proven track record of scaling innovative medical device companies and successful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results